Hello,
We are in the process of overhauling our personal insulin pump policy, order set, and process. We are interested in learning about how insulin pumps are handled within your institution/health system. If you are able, would love to see any clinical guidance, order set, or policy examples that you can share. Can you please answer the questions below:
1) Do you allow use of personal insulin pumps during acute admissions?
2) Exclusion criteria for personal insulin pump use (other than AMS or acuity
limiting ability to safely self-manage)?

Has anyone set up an EPIC dashboard (trending or operational) for Med Safety Metrics?

Looking to see if a dashboard would be a good way to monitor:
reversal agents (Narcan, Andexxa/Kcentra, Glucose/D10/D50);
BCMA compliance & least scanned medication;
Opioid stewardship / pain management prescribing patterns;
etc etc

If you have one, any info would be appreciated.

Does anyone have any specific strategies they have used to improve medication education with patients? We are looking to improve HCAHPS scores, but most importantly provide a system/process for our nurses to discuss what the medication is for and potential side effects.

Thank you for the help!

Does anyone have any specific strategies they have used to improve medication education with patients? We are looking to improve HCAHPS scores, but most importantly provide a system/process for our nurses to discuss what the medication is for and potential side effects.

Thank you for the help!

Does anyone have any specific strategies they have used to improve medication education with patients? We are looking to improve HCAHPS scores, but most importantly provide a system/process for our nurses to discuss what the medication is for and potential side effects.

Thank you for the help!

I am looking for information in regard to how other Cerner (Oracle) facilities handle the prescription bottle medication entries on the medication history. Currently our staff can only do a "add/modify compliance" function for those entries on the admission med history. This creates challenges for providers and pharmacy. If there are comments in the prescription like "take 2 tabs or take 1/2 tab, etc." then the order does not come across to pharmacy choosing the most appropriate product for the dose because the dose field has not technically been updated.

Our Health System is working on standardizing our standard phenylephrine concentration based on ASHP Adult Standard Concentration recommendations and USP 797 recommendations, "compounders must consider parameters that may affect quality, including but not limited to: Chemical and physical stability properties of the drug and/or its formulation." We currently utilize phenylephrine 10mg/250mL, but this concentration does not have stability data to support the concentration.

Does anyone have a protocol or list of meds that they allow to be administered in their ED triage/waiting areas, if they allow this at all? Does anyone allow use of IV meds in this area?

Hello
With our previous EPMA/CPOE we recorded the location of medication patches on a body map on a supplementary paper chart. This supplementary paper chart also had a section to record daily checks of the patch still being in place.
In our new electronic health record we would like to record the patch location on a body map, as it is more visual than describing the location in words.
We would also like to record that nurses have checked daily that the patch is still in place.

While I realize that ISMP endorses USP that the most prominent labelling on repackaged meds is total dose per container volume, I am looking for input regarding how your organization expresses concentration, if at all, on the container.